Literature DB >> 31519472

New evidence on the management of Lewy body dementia.

John-Paul Taylor1, Ian G McKeith2, David J Burn2, Brad F Boeve3, Daniel Weintraub4, Claire Bamford5, Louise M Allan6, Alan J Thomas2, John T O'Brien7.   

Abstract

Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegenerative conditions. Patients with Lewy body dementia present with a wide range of cognitive, neuropsychiatric, sleep, motor, and autonomic symptoms. Presentation varies between patients and can vary over time within an individual. Treatments can address one symptom but worsen another, which makes disease management difficult. Symptoms are often managed in isolation and by different specialists, which makes high-quality care difficult to accomplish. Clinical trials and meta-analyses now provide an evidence base for the treatment of cognitive, neuropsychiatric, and motor symptoms in patients with Lewy body dementia. Furthermore, consensus opinion from experts supports the application of treatments for related conditions, such as Parkinson's disease, for the management of common symptoms (eg, autonomic dysfunction) in patients with Lewy body dementia. However, evidence gaps remain and future clinical trials need to focus on the treatment of symptoms specific to patients with Lewy body dementia.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31519472      PMCID: PMC7017451          DOI: 10.1016/S1474-4422(19)30153-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  113 in total

1.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

2.  Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Authors:  B Ravina; M Putt; A Siderowf; J T Farrar; M Gillespie; A Crawley; H H Fernandez; M M Trieschmann; S Reichwein; T Simuni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 3.  Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.

Authors:  Shinji Matsunaga; Taro Kishi; Nakao Iwata
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis.

Authors:  Xiaona Zhang; Xiaoxuan Sun; Junhong Wang; Liou Tang; Anmu Xie
Journal:  Neurol Sci       Date:  2016-10-21       Impact factor: 3.307

5.  Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.

Authors:  Sandi Culo; Benoit H Mulsant; Jules Rosen; Sati Mazumdar; Richard E Blakesley; Patricia R Houck; Bruce G Pollock
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Oct-Dec       Impact factor: 2.703

Review 6.  The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.

Authors:  John V Hindle
Journal:  J Neural Transm (Vienna)       Date:  2013-02-22       Impact factor: 3.575

7.  Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies.

Authors:  Michele Terzaghi; Dario Arnaldi; Maria Cristina Rizzetti; Brigida Minafra; Riccardo Cremascoli; Valter Rustioni; Roberta Zangaglia; Chiara Pasotti; Elena Sinforiani; Claudio Pacchetti; Raffaele Manni
Journal:  Mov Disord       Date:  2013-06-06       Impact factor: 10.338

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

9.  Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  Victoria Larsson; Gustav Torisson; Margareta Bülow; Elisabet Londos
Journal:  Clin Interv Aging       Date:  2017-08-08       Impact factor: 4.458

10.  Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study.

Authors:  Miho Murata; Toshinari Odawara; Kazuko Hasegawa; Sayaka Iiyama; Masatoshi Nakamura; Masaaki Tagawa; Kenji Kosaka
Journal:  Neurology       Date:  2018-01-24       Impact factor: 9.910

View more
  33 in total

1.  Distal radius fractures and risk of incident neurocognitive disorders in older adults: a retrospective cohort study.

Authors:  Joshua M Baruth; Maria I Lapid; Bart Clarke; Alexander Y Shin; Elizabeth J Atkinson; Jonas Eberhard; Guido Zavatta; Jörgen Åstrand
Journal:  Osteoporos Int       Date:  2022-07-15       Impact factor: 5.071

2.  Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia.

Authors:  Jian Wang; Chakib Battioui; Andrew McCarthy; Xiangnan Dang; Hui Zhang; Albert Man; Jasmine Zou; Jeffrey Kyle; Leanne Munsie; Melissa Pugh; Kevin Biglan
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Mental health care for older adults: recent advances and new directions in clinical practice and research.

Authors:  Charles F Reynolds; Dilip V Jeste; Perminder S Sachdev; Dan G Blazer
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

Review 4.  Lewy Body Dementias: Controversies and Drug Development.

Authors:  Shannon Y Chiu; Dawn Bowers; Melissa J Armstrong
Journal:  Neurotherapeutics       Date:  2021-12-02       Impact factor: 6.088

Review 5.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

6.  Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.

Authors:  David Maltête; David Wallon; Julie Bourilhon; Romain Lefaucheur; Teodor Danaila; Stéphane Thobois; Luc Defebvre; Kathy Dujardin; Jean-Luc Houeto; Olivier Godefroy; Pierre Krystkowiak; Olivier Martinaud; André Gillibert; Mathieu Chastan; Pierre Vera; Didier Hannequin; Marie-Laure Welter; Stéphane Derrey
Journal:  Neurology       Date:  2020-11-16       Impact factor: 9.910

7.  Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers: An Interview Study.

Authors:  Melissa J Armstrong; Noheli Gamez; Slande Alliance; Tabassum Majid; Angela S Taylor; Andrea M Kurasz; Bhavana Patel; Glenn E Smith
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Oct-Dec 01       Impact factor: 2.703

8.  Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease.

Authors:  Calum A Hamilton; Fiona E Matthews; Paul C Donaghy; John-Paul Taylor; John T O'Brien; Nicola Barnett; Kirsty Olsen; Rory Durcan; Gemma Roberts; Joanna Ciafone; Sally A H Barker; Michael Firbank; Ian G McKeith; Alan J Thomas
Journal:  Neurology       Date:  2021-04-19       Impact factor: 9.910

9.  Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction.

Authors:  Mohsen Khosravi
Journal:  Eur J Transl Myol       Date:  2021-06-11

10.  The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease.

Authors:  Maria Angeles Prats-Sedano; George Savulich; Ajenthan Surendranathan; Paul C Donaghy; Alan J Thomas; James B Rowe; Li Su; John T O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2020-12-14       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.